U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H10ClFN2O
Molecular Weight 288.704
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORFLURAZEPAM

SMILES

FC1=C(C=CC=C1)C2=NCC(=O)NC3=C2C=C(Cl)C=C3

InChI

InChIKey=UVCOILFBWYKHHB-UHFFFAOYSA-N
InChI=1S/C15H10ClFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)

HIDE SMILES / InChI

Approval Year

Unknown
139594
Name Type Language
NORFLURAZEPAM
Common Name English
J13.722G
Code English
2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-
Systematic Name English
N-DESALKYL-2-OXOQUAZEPAM
Common Name English
NORFLUTOPRAZEPAM
Common Name English
FLURAZEPAM RELATED COMPOUND F [USP-RS]
Common Name English
SCH-17514
Code English
DESCARBETHOXYLOFLAZEPATE
Common Name English
CM-7116
Code English
FLURAZEPAM MONOHYDROCHLORIDE IMPURITY B [EP IMPURITY]
Common Name English
RO 5-3367
Common Name English
7-CHLORO-5-(2-FLUOROPHENYL)-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN-2-ONE
Systematic Name English
MIDAZOLAM IMPURITY F [EP IMPURITY]
Common Name English
NORFLUDIAZEPAM
Common Name English
DESALKYLFLURAZEPAM [NFLIS-DRUG]
Common Name English
FLURAZEPAM RELATED COMPOUND F
USP-RS  
Common Name English
N-DESALKYLFLURAZEPAM
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-NORFLURAZEPAM
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID30183057
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
ECHA (EC/EINECS)
220-748-3
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
SMS_ID
300000038159
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
CAS
2886-65-9
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
DRUG CENTRAL
809
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
RS_ITEM_NUM
1285603
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
PUBCHEM
4540
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
WIKIPEDIA
N-DESALKYLFLURAZEPAM
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
FDA UNII
X9U41NXR6M
Created by admin on Sat Dec 16 04:51:18 GMT 2023 , Edited by admin on Sat Dec 16 04:51:18 GMT 2023
PRIMARY
PARENT (METABOLITE ACTIVE)
Structure of MIDAZOLAM
PARENT (METABOLITE ACTIVE)
Structure of FLURAZEPAM
PARENT (METABOLITE ACTIVE)
Structure of FLUTAZOLAM
PARENT (METABOLITE ACTIVE)
Structure of ETHYL LOFLAZEPATE
PARENT (METABOLITE ACTIVE)
Structure of QUAZEPAM
PARENT (METABOLITE ACTIVE)
Structure of FLUDIAZEPAM
PARENT (METABOLITE ACTIVE)
Structure of FLUTOPRAZEPAM
SUBSTANCE RECORD
Structure of NORFLURAZEPAM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966